Skip to main content
WGS
NASDAQ Industrial Applications And Services

Key Insiders Continue Accumulating GeneDx Shares with $13.76M in New Purchases

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$40.378
Mkt Cap
$1.21B
52W Low
$32.21
52W High
$170.87
52W Position info
25% above low
Off High info
76% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

WGS sits 25% above its 52-week low of $32.21.

Summary

Key insiders, including Director Keith Meister's affiliated funds, have purchased an additional $13.76 million in GeneDx stock, signaling continued confidence after recent negative earnings news.


Key Events · Ownership and Investor Activity · WGS

  • Continued Insider Accumulation

    Investment funds advised by Corvex Management LP, controlled by Director and 10% owner Keith Meister, purchased an additional 351,273 shares of Class A common stock.

  • Significant Investment Value

    These open market purchases, made between May 13-15, 2026, totaled approximately $13.76 million.

  • Post-Earnings Conviction

    The buying activity follows the company's recent Q1 earnings miss and reduced full-year guidance, indicating strong insider confidence despite recent negative news.

  • Increased Beneficial Ownership

    Keith Meister's beneficial ownership now stands at 17.9% of the outstanding shares, while Eli Casdin's is 12%.


Analysis · WGS · Industrial Applications And Services

This Schedule 13D/A reports that investment funds advised by Corvex Management LP, controlled by Director and 10% owner Keith Meister, acquired an additional $13.76 million worth of GeneDx Holdings Corp. Class A common stock. These open market purchases, made between May 13-15, 2026, follow a recent period of significant insider accumulation, including over $46 million reported just days prior. The continued buying by key insiders, particularly after the company's recent Q1 earnings miss and reduced guidance, suggests strong conviction in the company's long-term prospects despite short-term challenges.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WGS was trading at $40.38 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $32.21 to $170.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WGS - Latest Insights

WGS
Nov 18, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $48.01
Real-time Price: $52.34 info
Change: +$4.33 (+9%) info
Market Cap: $1.557B info
WGS
Nov 18, 2026, 8:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $47.40
Real-time Price: $52.34 info
Change: +$4.94 (+10%) info
Market Cap: $1.557B info
WGS
Nov 10, 2026, 7:08 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $58.00
Real-time Price: $52.34 info
Change: -$5.66 (-10%) info
Market Cap: $1.557B info
WGS
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $52.34 info
Change: -$6.66 (-11%) info
Market Cap: $1.557B info
WGS
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $65.65
Real-time Price: $52.34 info
Change: -$13.31 (-20%) info
Market Cap: $1.557B info